
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group is well positioned for durable organic growth because open interest, volume, and retail participation are all trending higher, with August ADV at 29.7M, up 10% M/M and about 6% Y/Y, while 3Q activity ran about 7% above prior modeling. Its moat remains reinforced by pricing power, including a 2% rates increase, limited client leakage to FMX, and a broadening product mix spanning single stock futures, weekend metals trading, cash foreign exchange, fixed income, and compute futures. The company also benefits from high incremental margins, strong capital return prospects, and its 27% stake in S&P Dow Jones Indexes, which should support non-operating income and future earnings growth.
Bears say
CME Group is facing a negative setup because its earnings power depends heavily on sustained trading activity and pricing, yet deceleration in Average Daily Volume and weaker Revenue per Contract trends can quickly pressure revenue. Competitive threats are also material, with FMX, CBOE, and ICE cited as potential share takers in rates, equities, and energy, while the 2007, 2008, and 2018 acquisitions add integration and execution risk if revenue or OpEx guidance disappoints. Macro sensitivity and regulatory overhang further cloud the outlook, especially as net investment income is already 10%+ of adjusted pretax income and could be disrupted if market structure shifts.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares